D+R LATHIAN

What D+R LATHIAN does

D+R LATHIAN, legally D&R Communications, LLC d/b/a D+R LATHIAN, is a U.S.-based multichannel healthcare marketing agency founded in 1999 by co-founder David Schoonmaker and headquartered in Freehold, New Jersey. The company specializes in connecting life sciences companies (pharmaceutical and biotechnology firms) with healthcare providers (HCPs) through branded and unbranded medical content delivered via an invite-only HCP portal called MyDrugRep.com. Its client base spans 60 life sciences companies, 115 brands, and 20 therapeutic categories, with a claimed reach of over 806,000 physicians, of whom the company states more than 28% are actively engaged with platform content. Notable customers identified on the company website include Boehringer Ingelheim, Bristol Myers Squibb, Sanofi, Regeneron, Daiichi Sankyo, EMD Serono, BioMarin, Exelixis, and ViiV Healthcare.

The core technology asset is the MyDrugRep.com platform, which leverages HCP-level data and NPI-level matching to align physician records with verified email identities (typical match rates stated above 85%) and to enable data-driven Next Best Actions (NBAs) by specialty, treatment preference, diagnostic preference, demographics, and geography. The omnichannel offering combines a strategic layer (NBAs, sales force integration, trigger-based and gap coverage initiatives, audience segmentation, message sequencing), a digital layer (interactive carousel emails, interactive learning modules, banner ads, social media placements, virtual sales videos), and a print layer (retention mailers, rep handouts, in-office tools, video-in-print) tied together by analytics-enabled QR codes. Trademark filings protect the DRLATHIAN.com, detailrep.com, drugrep.com, and edrugrep.com service marks, plus "Virtual Drug Rep" and "Virtual Detail" sub-brands.

The business model is enterprise B2B services sold to life sciences brand teams through a consultative, Zoom-led sales motion with no public pricing — effectively a quote-based engagement model. Revenue streams span HCP platform services (recurring access to the MyDrugRep.com audience), strategic marketing solutions (custom omnichannel programs), and full-service campaign management (managed services). Pricing, unit economics, and revenue figures are not disclosed. The company is presently being acquired by Health Monitor Network, as evidenced by a breaking-news banner on its website linking to the acquirer's press release.

Name

D+R LATHIAN

Legal name

D&R Communications, LLC d/b/a D+R LATHIAN

Website

https://drlathian.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

1–10 employees

Short description

D+R LATHIAN is a U.S.-based multichannel healthcare marketing agency that connects pharmaceutical and biotechnology clients with physicians via its invite-only HCP portal, MyDrugRep.com, delivering branded and unbranded medical content across digital and print channels.

Ownership category

akta.pro rank

Headquarters

HQ city

East Brunswick

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. HCP Platform Services: MyDrugRep.com platform serves as the core product, providing branded and unbranded medical content to healthcare providers on behalf of life science company clients. Revenue appears to be generated through service fees to pharmaceutical and biotech companies for accessing the HCP audience and running campaigns.
2. Strategic Marketing Solutions: Customizable omnichannel marketing solutions including strategic consulting, digital tactics, and print materials for life science brands.
3. Campaign Management: Full-service campaign execution including sales force integration, trigger-based initiatives, gap coverage, audience segmentation, and message sequencing.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

D+R LATHIAN operates MyDrugRep.com, an invite-only HCP portal that furnishes branded and unbranded medical content from life sciences companies to over 806,000 physicians across 20 therapeutic categories. The company delivers fully customizable omnichannel marketing solutions spanning strategic consulting, digital tactics (interactive emails, learning modules, virtual sales videos, banner ads, social placements), and print engagement (retention mailers, rep handouts, in-office tools, video-in-print) tied together through analytics-enabled QR codes and NPI-level physician matching.

Product overview

D+R LATHIAN operates as a multichannel marketing specialist connecting healthcare providers with life science companies. The core product is the MyDrugRep.com platform—an invite-only HCP portal that delivers branded and unbranded medical content across multiple channels. The platform is supported by a suite of digital tactics (Interactive Carousel Emails, Interactive Learning Modules, Virtual Sales Videos, banner ads, social media placements) and print solutions (retention mailers, rep handouts, in-office tools, video-in-print). Strategic add-on capabilities include Next Best Actions powered by HCP-level data, Sales Force Integration, and audience segmentation. The company also markets under sub-brands including Virtual Drug Rep and Virtual Detail.

Differentiator

Problem solved

Functional benefit

Brands

• MyDrugRep.com: An invite-only HCP (Healthcare Provider) portal that furnishes branded and unbranded medical content for life sciences companies. Platform has served 60 life sciences companies, 115 brands, 20 therapeutic categories, and 296 campaigns.

Products and services

• MyDrugRep.com

Quantifiable outcome

• 32% higher email open rates vs. industry benchmarks
• +3 more outcomes

Named customers22 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators9 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• PatientPoint: Point-of-care health marketing network reaching HCPs and patients in offices and through digital platforms. Comparable as a multichannel HCP marketing and content platform serving pharma brands with measurable engagement.

Broad incumbents

• Outcome Health: Healthcare decision-placement platform at point-of-care delivering HCP and patient content; now part of PATIENTPOINT and serving major pharma brands. Comparable HCP/patient engagement platform serving the same pharma commercial budgets.
• Veeva Systems: Enterprise cloud and data platform for life sciences, including Veeva CRM, Veeva Vault, and multichannel HCP engagement solutions. Comparable as a software-driven HCP marketing and engagement vendor serving the same enterprise pharma/biotech customer base.
• Syneos Health: Contract sales, medical affairs, and health marketing services provider to pharma/biotech. Comparable as a full-service commercial partner running HCP-targeted campaigns and outsourced promotion, with similar customers and channels.
• Havas Health & You: Global healthcare communications network offering creative, media, and patient/HCP engagement services to pharma and biotech. Similar enterprise agency model and multichannel HCP engagement offering.
• IQVIA: Global healthcare data, analytics, and commercial services firm offering HCP/consumer marketing, promotional effectiveness, and sales force solutions. Overlaps with D+R Lathian's data-driven HCP targeting and omnichannel campaign execution capabilities.
• Health Monitor Network: Acquirer of D+R Lathian per the website's breaking news banner. Operates a much broader point-of-care, HCP, and consumer health marketing platform across print, digital, and live channels; highly comparable as a multichannel healthcare marketing specialist serving life sciences clients.
• Publicis Health: Healthcare-focused creative and media agency within Publicis Groupe serving pharma, biotech, and consumer health. Direct comparable to D+R Lathian's multichannel healthcare creative agency positioning for life sciences clients.

Direct peers

• Concentric Health Experience: Independent healthcare marketing agency offering omnichannel HCP and consumer engagement for pharmaceutical and biotech clients. Comparable independent creative-and-platform model for life sciences commercial teams.
• AbelsonTaylor: Independent, award-winning healthcare creative agency specialized in pharma, biotech, and DTC campaigns. Closely matches D+R Lathian's healthcare creative agency model serving enterprise life sciences clients with omnichannel storytelling.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/drlathian

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about D+R LATHIAN